References
- De Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol. 2006;17:2120–2126.
- Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non-diabetic individuals. JAMA. 2001;286: 421–426.
- Ritz E. Heart and kidney: Fatal twins? Am J Med. 2006;119:S31–S39.
- Tapp RJ, Shaw JE, Zimmet PZ, et al. Albuminuria is evident in the early stages of diabetes onset: Results from the Australian Diabetes, Obesity, and Lifestyle Study (Aus-Dia). Am J Kidney Dis. 2004;44:792–798.
- Araki S, Haneda H, Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–2987.
- Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant. 2004;19:2784–2788.
- Alberti KG, Zimmet PG. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of WHO consultation. Diabet Med. 1998;15:539–553.
- Ono T, Shikata K, Okiba M, Miyatake N, Kotera R, Makino H. Factors associated with remission and/or regression of microalbuminuria in type 2 diabetes mellitus. Acta Medica Okayama. 2014;44:235–241.
- Yokoyama H, Araki SI, Honjo J, Okiazaki S, Yamada D, Haneda M. Association between remission of macroalbuminuria and preservation of renal function in patients with Type 2 Diabetes with overt proteinuria. Diabetes Care. 2013;36:3227–3233.